Current Pharmacogenomics


Adrián LLerena , MD, Ph.D
Extremadura University
Hospital and Medical School
Badajoz, Extremadura


Volume 5 - Issue 4

Prognostic and Predictive Markers in Colorectal Cancer – The Role of New Genomic Technologies

Volume: 5   Issue: 4
Pp: 255-261
Vicky M. Coyle, Wendy L. Allen, Daniel B. Longley and Patrick G. Johnston
DOI: 10.2174/157016007782793728

Genetic Polymorphisms of Human Sulfate Transporters

Volume: 5   Issue: 4
Pp: 262-274
Paul A. Dawson and Daniel Markovich
DOI: 10.2174/157016007782793692

Tumour Necrosis Factor α Gene Promoter and its Role in Rheumatoid Arthritis Outcome and Pharmacogenetics

Volume: 5   Issue: 4
Pp: 275-279
Joao Eurico Fonseca, Jose Teles and Mario Viana Queiroz
DOI: 10.2174/157016007782793674

The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs

Volume: 5   Issue: 4
Pp: 292-313
Ian R. Phillips, Asvi A. Francois and Elizabeth A. Shephard
DOI: 10.2174/157016007782793683

Connexin Genes as Promising Therapeutic Targets in Cancers

Volume: 5   Issue: 4
Pp: 314-318
Tomohiro Yano, Hiromi Sato, Hiromi Hagiwara and Nantiga Virgona
DOI: 10.2174/157016007782793737